Literature DB >> 18443752

New insights into the role of angiotensin-converting enzyme obtained from the analysis of genetically modified mice.

Xiao Z Shen1, Hong D Xiao, Ping Li, Chentao X Lin, Sandrine Billet, Derick Okwan-Duodu, Jon W Adams, Ellen A Bernstein, Yi Xu, Sebastien Fuchs, Kenneth E Bernstein.   

Abstract

Angiotensin-converting enzyme (ACE) has been well-recognized for its role in blood pressure regulation. ACE is made by many tissues, though it is most abundantly expressed on the luminal surface of vascular endothelium. ACE knockout mice show a profound phenotype with low blood pressure, but also with hemopoietic and developmental defects, which complicates understanding the biological functions of ACE in individual tissue types. Using a promoter-swapping strategy, several mouse lines with unique ACE tissue expression patterns were studied. These include mice with ACE expression in the liver (ACE 3/3), the heart (ACE 8/8), and macrophages (ACE 10/10). We also investigated mice with a selective inactivation of either the N- or C-terminal ACE catalytic domain. Our studies indicate that ACE plays a role in many other physiologic processes beyond simple blood pressure control.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18443752      PMCID: PMC6167991          DOI: 10.1007/s00109-008-0325-3

Source DB:  PubMed          Journal:  J Mol Med (Berl)        ISSN: 0946-2716            Impact factor:   4.599


  36 in total

1.  Poly(ADP-ribose) polymerase-1-deficient mice are protected from angiotensin II-induced cardiac hypertrophy.

Authors:  Jyothish B Pillai; Madhu Gupta; Senthilkumar B Rajamohan; Roberto Lang; Jai Raman; Mahesh P Gupta
Journal:  Am J Physiol Heart Circ Physiol       Date:  2006-04-21       Impact factor: 4.733

2.  Inhibitor of hematopoietic pluripotent stem cell proliferation: purification and determination of its structure.

Authors:  M Lenfant; J Wdzieczak-Bakala; E Guittet; J C Prome; D Sotty; E Frindel
Journal:  Proc Natl Acad Sci U S A       Date:  1989-02       Impact factor: 11.205

3.  Drosophila melanogaster angiotensin I-converting enzyme expressed in Pichia pastoris resembles the C domain of the mammalian homologue and does not require glycosylation for secretion and enzymic activity.

Authors:  T A Williams; A Michaud; X Houard; M T Chauvet; F Soubrier; P Corvol
Journal:  Biochem J       Date:  1996-08-15       Impact factor: 3.857

4.  Mice lacking endothelial angiotensin-converting enzyme have a normal blood pressure.

Authors:  Justin Cole; Du Le Quach; Karthik Sundaram; Pierre Corvol; Mario R Capecchi; Kenneth E Bernstein
Journal:  Circ Res       Date:  2002-01-11       Impact factor: 17.367

5.  Cardiac-restricted angiotensin-converting enzyme overexpression causes conduction defects and connexin dysregulation.

Authors:  Vijaykumar S Kasi; Hong D Xiao; Lijuan L Shang; Shahriar Iravanian; Jonathan Langberg; Emily A Witham; Zhe Jiao; Carlos J Gallego; Kenneth E Bernstein; Samuel C Dudley
Journal:  Am J Physiol Heart Circ Physiol       Date:  2007-03-02       Impact factor: 4.733

Review 6.  Angiotensin II receptor blocker: possibility of antitumor agent for prostate cancer.

Authors:  Hiroji Uemura; Hitoshi Ishiguro; Yoshinobu Kubota
Journal:  Mini Rev Med Chem       Date:  2006-07       Impact factor: 3.862

7.  Mice with cardiac-restricted angiotensin-converting enzyme (ACE) have atrial enlargement, cardiac arrhythmia, and sudden death.

Authors:  Hong D Xiao; Sebastien Fuchs; Duncan J Campbell; William Lewis; Samuel C Dudley; Vijaykumar S Kasi; Brian D Hoit; George Keshelava; Hui Zhao; Mario R Capecchi; Kenneth E Bernstein
Journal:  Am J Pathol       Date:  2004-09       Impact factor: 4.307

8.  Mice lacking angiotensin-converting enzyme have low blood pressure, renal pathology, and reduced male fertility.

Authors:  C R Esther; T E Howard; E M Marino; J M Goddard; M R Capecchi; K E Bernstein
Journal:  Lab Invest       Date:  1996-05       Impact factor: 5.662

Review 9.  Effect of angiotensin II blockade on cardiac hypertrophy and remodelling: a review.

Authors:  B Dahlöf
Journal:  J Hum Hypertens       Date:  1995-11       Impact factor: 3.012

10.  Role of the N-terminal catalytic domain of angiotensin-converting enzyme investigated by targeted inactivation in mice.

Authors:  Sebastien Fuchs; Hong D Xiao; Justin M Cole; Jonathan W Adams; Kristen Frenzel; Annie Michaud; Hui Zhao; George Keshelava; Mario R Capecchi; Pierre Corvol; Kenneth E Bernstein
Journal:  J Biol Chem       Date:  2004-02-02       Impact factor: 5.157

View more
  5 in total

1.  20-HETE Activates the Transcription of Angiotensin-Converting Enzyme via Nuclear Factor-κB Translocation and Promoter Binding.

Authors:  Victor Garcia; Brian Shkolnik; Laura Milhau; John R Falck; Michal Laniado Schwartzman
Journal:  J Pharmacol Exp Ther       Date:  2015-12-23       Impact factor: 4.030

2.  Interpretable correlation descriptors for quantitative structure-activity relationships.

Authors:  Benson M Spowage; Craig L Bruce; Jonathan D Hirst
Journal:  J Cheminform       Date:  2009-12-24       Impact factor: 5.514

3.  Vascular wall ACE is not required for atherogenesis in ApoE(-/-) mice.

Authors:  Daiana Weiss; Kenneth E Bernstein; Sebastian Fuchs; Jonathan Adams; Andreas Synetos; W Robert Taylor
Journal:  Atherosclerosis       Date:  2009-10-06       Impact factor: 5.162

Review 4.  Emergence and evolution of the renin-angiotensin-aldosterone system.

Authors:  David Fournier; Friedrich C Luft; Michael Bader; Detlev Ganten; Miguel A Andrade-Navarro
Journal:  J Mol Med (Berl)       Date:  2012-04-14       Impact factor: 4.599

5.  Will the real angiotensin converting enzyme please stand up?

Authors:  Friedrich C Luft
Journal:  J Mol Med (Berl)       Date:  2012-06       Impact factor: 4.599

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.